Open AccessEfalizumab-Associated Papular Psoriasis
Author(s) -
Akmal S. Hassan,
D Simon,
HansUwe Simon,
Lasse R. Braathen,
Nikhil Yawalkar
Publication year - 2007
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.143.7.900
Subject(s) - efalizumab , medicine , psoriasis , pathology , cd68 , monoclonal antibody , dermatology , immunohistochemistry , immunology , antibody , plaque psoriasis
Efalizumab is a human anti-CD11a monoclonal antibody used in the treatment of patients with moderate to severe plaque psoriasis. Some of the patients develop new papular lesions during treatment, which are predominantly located in the flexural regions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom